Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

Part of paid clinical trials in Camden, New Jersey.

Sponsor
The Cooper Health System
Study ID
NCT05203328
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vapotherm — DEVICE
    Monitored anesthesia care with oxygen supplementation through a high-flow nasal cannula
  • Regular nasal canula — DEVICE
    Monitored anesthesia care with oxygen supplementation through a regular nasal cannula

Study Details

Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.

Key Dates

Start date
Feb 1, 2022
Status verified
Sep 2025
Primary completion
Mar 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
198 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: High flow nasal cannula oxygen
    High flow nasal cannula oxygen will be provided during the procedure using a Vapotherm device
  • Active Comparator: Regular nasal cannula
    Regular nasal cannula oxygen will be provided during the procedure

Primary Outcome Measure

Number of interruption during EBUS procedure for hypoxia [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cooper University HospitalCamdenNew Jersey08103
Wissam Abouzgheib, MD
800-826-6737
Christopher Ambrogi, DO
Wissam Abouzgheib, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Camden, NJ

By condition

Related Studies